Globus Medical, Inc.
GMED
Clasificación en acciones
#1983
Globus Medical, Inc. is a global medical technology company dedicated to... Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Precio por acción
$79.05
Última sincronización: 2026-10-20
Capitalización bursátil
$10.61B
Cambio (1 día)
4.29%
Cambio (1 año)
26.02%
País
US
Comercio Globus Medical, Inc. (GMED)
Categoría
Healthcare
Ratio P/B de Globus Medical, Inc. (GMED)
Ratio P/B al October 2026 TTM: 2.17
Según los informes financieros más recientes y el precio de las acciones de Globus Medical, Inc., el ratio P/B actual (TTM) es 2.17. Al final de 2023, el ratio P/B era 1.51.
Historial del ratio P/B de Globus Medical, Inc. desde 2009 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 2.17 | -19.47% |
| 2024 | 2.69 | 78.27% |
| 2023 | 1.51 | -62.70% |
| 2022 | 4.04 | -3.24% |
| 2021 | 4.18 | -2.15% |
| 2020 | 4.27 | 2.54% |
| 2019 | 4.16 | 16.49% |
| 2018 | 3.57 | -12.57% |
| 2017 | 4.09 | 43.32% |
| 2016 | 2.85 | -22.85% |
| 2015 | 3.70 | -3.38% |
| 2014 | 3.83 | -3.34% |
| 2013 | 3.96 | 62.75% |
| 2012 | 2.43 | -29.99% |
| 2011 | 3.47 | -19.22% |
| 2010 | 4.30 | 0.00% |
| 2009 | 0.00 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 3.5116 | 62.11% |
US
|
|
| 2.0146 | -7.00% |
IE
|
|
| 4.5025 | 107.85% |
US
|
|
| 2.5486 | 17.65% |
US
|
|
| - | - |
DE
|
